NewsFlash Archive

more Events

Subscribe

  • 0%
    0 votes

    Vitamin D Linked to Autoimmune and Cancer Disease Genes, Underscoring Risks of Deficiency

    Tuesday, August 24, 2010

    Vitamin D insufficiency is a risk factor for a number of diseases and thus, is a growing concern worldwide, as approximately one billion people may be vitamin D deficientHowever, the biological basis for vitamin D deficiency predisposing to disease is poorly understood. In a report published onlin

    read more>>

  • 0%
    0 votes

    UCLA Study Identifies Genetic Variation Linked to Lupus in Asian Men

    Tuesday, August 24, 2010

    Genes reside along long chains of DNA called chromosomesUCLA researchers have found that a variation in a gene on the sex chromosome X may enhance an immune response that leads to lupus in menSystemic lupus erythematosus (SLE) is an autoimmune disease that predominantly affects women. Interesting

    read more>>

  • 0%
    0 votes

    Rectal Cancer Rates Are Rising in Young Individuals

    Monday, August 23, 2010

    A new analysis has found that while colon cancer rates have remained steady over the past several decades among people under the age of 40, rectal cancer rates are increasing in this population across races and in both sexesPublished early online in Cancer, a peer-reviewed journal of the American

    read more>>

  • 0%
    0 votes

    New Compound May Be Effective Against Chagas' Disease

    Monday, August 23, 2010

    A new compound may offer an effective drug candidate against the deadly tropical infection, Chagas’ disease say researchers from BrazilThey report their findings in the August 2010 issue of the journal Antimicrobial Agents and ChemotherapyChagas’ disease is an infection caused by the

    read more>>

  • 0%
    0 votes

    Virus May Act as "Evolution-Proof" Biopesticide Against Malaria

    Monday, August 23, 2010

    A naturally occurring virus in mosquitoes may serve as a “late-life-acting” insecticide by killing older adult mosquitoes that are responsible for the bulk of malaria transmissionThe researchers from Johns Hopkins University and the Johns Hopkins Malaria Research Institute, Baltimore,

    read more>>

  • 0%
    0 votes

    Novel 'Antisense' Therapies Protect Primates From Lethal Ebola and Marburg Viruses

    Monday, August 23, 2010

    New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg virusesFurthermore, the animals were protected even when therapeutics were administered one hour after exposure—suggesting the approach holds promise for treating accidenta

    read more>>

  • 0%
    0 votes

    Gene Scan Finds Link Across Array of Childhood Brain Disorders

    Monday, August 23, 2010

    Mutations in a single gene can cause several types of developmental brain abnormalities that experts have traditionally considered different disordersWith support from the National Institutes of Health, researchers found those mutations through whole exome sequencing – a new gene scanning te

    read more>>

  • 0%
    0 votes

    Putting the Squeeze on Alzheimer's

    Monday, August 23, 2010

    DAVIS, Calif. -- Brain cells exposed to a form of the amyloid beta protein, the molecule linked to Alzheimer's disease, become stiffer and bend less under pressure, researchers at UC Davis have foundThe results reveal one mechanism by which the amyloid protein damages the brain, a finding that cou

    read more>>

  • 0%
    0 votes

    Rheumatoid Arthritis Signaling Protein Reverses Alzheimer's Disease in Mouse Model

    Monday, August 23, 2010

    Tampa, FL -- A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer's disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease, a new study by the University of South Florida reportsResearchers found tha

    read more>>

  • 0%
    0 votes

    Bolder BioTechnology Announces $600,000 Grant From NIH to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome

    Friday, August 20, 2010

    BOULDER, Colo. -- Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIHThe grant will be used t

    read more>>